s6y
Company name or ticker
Search
Prelude Therapeutics Inc
DRS
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Filed
Thursday, July 23, 2020
Accession number
0000950123-20-007154
Documents
filename1.htm
DRS
filename2.htm
EX-10.5
filename3.htm
EX-21.1
On sec.gov
Filing index
All files
Complete submission text
SGML header